ATOSSA THERAPEUTICS I
1,5000
08-ноября-24 14:59:57
15 мин. задержка
Акции
0,0000
0,00%
Сегодняшний диапазон
1,4500 - 1,5050
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Atossa Therapeutics Announces Support of New Breast Cancer Screening Guidelines
07 май 2024 07:30:00 Источник Nasdaq GlobeNewswire
-
29 апр 2024 07:30:00 Источник Nasdaq GlobeNewswire
-
15 апр 2024 07:30:00 Источник Nasdaq GlobeNewswire
-
Atossa to Participate in Noble Capital Markets Emerging Growth Healthcare Conference
11 апр 2024 07:30:00 Источник Nasdaq GlobeNewswire
-
09 апр 2024 10:59:00 Источник Nasdaq GlobeNewswire
-
NetDania - New 12 months High: ATOSSA THERAPEUTICS INC. - COMMON STOCK
05 апр 2024 08:58:53 Источник NetDania Notify
-
NetDania - New 12 months High: ATOSSA THERAPEUTICS INC. - COMMON STOCK
04 апр 2024 10:38:29 Источник NetDania Notify
-
Atossa Therapeutics Announces Year-End 2023 Financial Results and Provides Corporate Update
01 апр 2024 15:00:00 Источник Nasdaq GlobeNewswire
-
NetDania - New 12 months High: ATOSSA THERAPEUTICS INC. - COMMON STOCK
01 апр 2024 11:27:21 Источник NetDania Notify
-
NetDania - New 12 months High: ATOSSA THERAPEUTICS INC. - COMMON STOCK
28 мар 2024 09:08:00 Источник NetDania Notify
-
NetDania - New 12 months High: ATOSSA THERAPEUTICS INC. - COMMON STOCK
26 мар 2024 08:45:03 Источник NetDania Notify
-
NetDania - New 12 months High: ATOSSA THERAPEUTICS INC. - COMMON STOCK
25 мар 2024 09:40:51 Источник NetDania Notify
-
NetDania - New 12 months High: ATOSSA THERAPEUTICS INC. - COMMON STOCK
20 мар 2024 08:45:01 Источник NetDania Notify
-
NetDania - New 12 months High: ATOSSA THERAPEUTICS INC. - COMMON STOCK
19 мар 2024 09:49:14 Источник NetDania Notify
-
19 мар 2024 07:30:00 Источник Nasdaq GlobeNewswire
-
Atossa Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Listing Requirements
18 мар 2024 07:30:00 Источник Nasdaq GlobeNewswire
-
12 мар 2024 07:30:00 Источник Nasdaq GlobeNewswire
-
06 мар 2024 07:30:00 Источник Nasdaq GlobeNewswire
-
Atossa Therapeutics Announces First Patient Dosing of (Z)-Endoxifen in the Ongoing RECAST DCIS Study
22 фев 2024 07:30:00 Источник Nasdaq GlobeNewswire
-
Atossa Therapeutics Announces Full Enrollment of (Z)-Endoxifen Arm of I-SPY 2 Clinical Trial
07 фев 2024 07:30:00 Источник Nasdaq GlobeNewswire